Q2 2026
EPS
$1.97
est $1.82+8.2%
Revenue
$2.51B
est $2.40B+4.7%
Eastman Chemical cleared earnings expectations by 8.2% as its Chemical Intermediates segment flipped to a $58 million profit from a $30 million loss a year ago, fueled by 39% revenue growth from Middle East supply disruptions that drove prices and volumes higher. Sequential margins expanded 350 basis points on disciplined pricing in specialties, though management trimmed full-year cash flow guidance to $900 million as inflationary pressure on receivables bites.
